Literature DB >> 3817908

Oligonucleotide genotyping shows that alleles at the HLA-DR beta III locus of the DRw52 supertypic group segregate independently of known DR or Dw specificities.

J Gorski, M Tilanus, M Giphart, B Mach.   

Abstract

Using locus- and allele-specific oligonucleotide probes, we have studied the polymorphism of the HLA-DR beta III locus within the haplotypes of the DRw52 supertypic group. DNA from a number of homozygous typing cells typed for both Dw and DR was used. The DR beta III polymorphisms, DRw52a and DRw52b, do not segregate with Dw typing, or with DR typing, indicating that the determinants responsible for Dw-defined T-cell response and for DR haplotypic recognition are not encoded by the DR beta III locus. Hence, we can conclude that these DR specificities are encoded by the other functional DR locus, DR beta I, while the DR beta III locus encodes only the supertypic product.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3817908     DOI: 10.1007/bf00364271

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  10 in total

1.  Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.

Authors:  R Sorrentino; J Lillie; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

2.  High-resolution analysis of the human HLA-DR polymorphism by hybridization with sequence-specific oligonucleotide probes.

Authors:  G Angelini; C de Preval; J Gorski; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals.

Authors:  M G Tilanus; B Morolli; M C van Eggermond; G M Schreuder; R R de Vries; M J Giphart
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Complete characterization and sequence of an HLA class II DR beta chain cDNA from the DR5 haplotype.

Authors:  V L Tieber; L F Abruzzini; D K Didier; B D Schwartz; P Rotwein
Journal:  J Biol Chem       Date:  1986-02-25       Impact factor: 5.157

5.  Structural organization of the DR subregion of the human major histocompatibility complex.

Authors:  T Spies; R Sorrentino; J M Boss; K Okada; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

6.  Linkage map of three HLA-DR beta-chain genes: evidence for a recent duplication event.

Authors:  P Rollini; B Mach; J Gorski
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

7.  cDNA clones for the heavy chain of HLA-DR antigens obtained after immunopurification of polysomes by monoclonal antibody.

Authors:  A J Korman; P J Knudsen; J F Kaufman; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  cDNA clones coding for the heavy chain of human HLA-DR antigen.

Authors:  J S Lee; J Trowsdale; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

9.  Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes.

Authors:  E O Long; C T Wake; J Gorski; B Mach
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Serological and immunochemical analysis of the products of a single HLA DR-alpha and DR-beta chain gene expressed in a mouse cell line after DNA-mediated cotransformation reveals that the beta chain carries a known supertypic specificity.

Authors:  J Gorski; R Tosi; M Strubin; C Rabourdin-Combe; B Mach
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

  10 in total
  11 in total

1.  HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis.

Authors:  P C Stokkers; P H Reitsma; G N Tytgat; S J van Deventer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Characterization of an HLA-DR beta pseudogene in the DRw52 supertypic group.

Authors:  P Rollini; B Mach; J Gorski
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  DNA typing of HLA-DR beta chain genes can discriminate between undetected alleles and real homozygotes.

Authors:  C de Préval; G Angelini; B Boogh; G B Ferrara; B Mach
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  Serological recognition of HLA-DR allodeterminant corresponding to DNA sequence involved in gene conversion.

Authors:  C C Berte; N Tanigaki; R Tosi; J Gorski; B Mach
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

5.  Structural comparison of the genes of two HLA-DR supertypic groups: the loci encoding DRw52 and DRw53 are not truly allelic.

Authors:  J Gorski; P Rollini; B Mach
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease.

Authors:  A Cariappa; B Sands; D Forcione; D Finkelstein; D K Podolsky; S Pillai
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

7.  An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele.

Authors:  D G Forcione; B Sands; K J Isselbacher; A Rustgi; D K Podolsky; S Pillai
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

8.  Identification and distribution of three serologically undetected alleles of HLA-DR by oligonucleotide.DNA typing analysis.

Authors:  J M Tiercy; J Gorski; M Jeannet; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

9.  Treatment with cyclosporin and risks of graft rejection in male kidney and heart transplant recipients with non-O blood.

Authors:  G F Hendriks; E P van Steenberge; G M Schreuder; G J Wenting; B Mochtar; E Bos; M L Simoons; A H Balk; K Laird-Meeter; C E Essed
Journal:  BMJ       Date:  1988-10-08

10.  A cellular and functional split in the DRw8 haplotype is due to a single amino acid replacement (DR beta ser 57- asp 57).

Authors:  A K Jonsson; L Andersson; L Rask
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.